Platelet collagen receptors and fibrin formation pathway components

Platelet collagen receptors and fibrin formation pathway components encompass the molecular machinery responsible for blood clot formation and stabilization. Key receptors like Glycoprotein VI (GPVI) and Integrin alpha-2/beta-1 allow platelets to bind to exposed collagen at injury sites, triggering activation and aggregation (Source: UniProt, Q9HCN6). This process is coupled with the coagulation cascade, where enzymes like Factor Xa and Thrombin (Factor IIa) facilitate the production of fibrin from fibrinogen to reinforce the platelet plug (Source: StatPearls, Physiology, Coagulation Cascade). These components are major therapeutic targets for treating and preventing thrombotic disorders such as myocardial infarction, stroke, and deep vein thrombosis. Drugs targeting this system include direct thrombin inhibitors, Factor Xa inhibitors, and experimental GPVI antagonists (Source: PubMed, PMID: 23102430). However, the clinical use of most agents in this category is often limited by the inherent risk of major bleeding, as these pathways are also essential for normal wound healing.

Other names

Platelet-collagen axisCoagulation cascadeHemostatic pathway componentsGPVI-Integrin-Thrombin axis

Inhibition of platelet adhesion to collagen, inhibition of thrombin-mediated fibrinogen cleavage, and inhibition of factor Xa-mediated prothrombin activation.